H. Karen Vousden's Insider Trades & SAST Disclosures
H. Karen Vousden's most recent trade in Bristol-Myers Squibb Co. was a trade of 3,562 Deferred Share Units done . Disclosure was reported to the exchange on Feb. 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern H. Karen Vousden.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bristol-Myers Squibb Co. | Karen H. Vousden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 3,562 | 35,232 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | H. Karen Vousden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 4,314 | 30,211 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Karen H. Vousden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 2,807 | 24,860 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Karen H. Vousden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 3,067 | 21,414 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Karen H. Vousden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 3,054 | 17,779 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Karen H. Vousden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2020 | 156 | 14,609 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Karen H. Vousden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 160 | 14,345 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Karen H. Vousden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 164 | 14,077 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Karen H. Vousden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2020 | 173 | 13,809 | - | - | Deferred Share Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges